DME Capital Management (Greenlight, David Einhorn)
DME Capital Management (Greenlight, David Einhorn) (DME Capital Management, LP) reported 45 positions worth $3.55B as of September 30, 2026 (13F filed November 16, 2026). Largest holding: GRBK (17.6%). Biggest move: new buy CENX ($81.7M).
| # | Symbol | Company | Value ↓ | % Port. | Time Held | Shares | Est. Buy Price | Gain | 1Y | YTD | Since reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ▸ 1 | GRBK | $625.9M | 17.61% | >10 Years | 9,467,383 | — | — | — | — | -9.3% | |
| ▸ 2 | FLR | $220.6M | 6.21% | 1.5 Years | 4,607,666 | $41.78 | +15.8% | — | — | +1.1% | |
| ▸ 3 | CNR | $193.7M | 5.45% | 1.8 Years | 2,255,990 | $85.24 | -1.9% | — | — | -2.6% | |
| ▸ 4 | VGNT | $144.7M | 4.07% | 2 Q | 3,220,500 | $41.21 | -0.2% | — | — | -8.5% | |
| ▸ 5 | BHF | $141.8M | 3.99% | 9.3 Years | 2,842,100 | $56.14 | -23.6% | — | — | -14.1% | |
| ▸ 6 | PCG | $122.5M | 3.45% | 1.3 Years | 10,000,000 | $15.24 | -10.2% | — | — | +11.7% | |
| ▸ 7 | ACHC | $121.0M | 3.41% | 2 Years | 4,400,641 | $20.92 | +85.0% | — | — | +40.7% | |
| ▸ 8 | CNC | $102.6M | 2.89% | 2 Years | 1,651,150 | $42.91 | +74.2% | — | — | +20.4% | |
| ▸ 9 | DHT | $96.6M | 2.72% | 3.3 Years | 4,281,242 | $10.28 | +109.0% | — | — | -4.8% | |
| ▸ 10 | DCH | $96.1M | 2.70% | 3 Q | 18,411,629 | $6.3378 | -28.4% | — | — | -13.0% |
Related managers
Five closest superinvestors by Jaccard overlap of tickers held in the latest quarter (computed nightly).
| Manager | Overlap | Shared holdings |
|---|---|---|
| Greenlight Capital (David Einhorn) | 13.3% | GPK, GRBK, BHF, GLD, NUVB, LKFT, SHC, DHT +2 |
| Miller Value Partners (Bill Miller) | 5.4% | CROX, REZI, VTRS, DCH, ADIG |
| Corvex Management | 4.3% | FLR, MGM, GLD |
| First Pacific Advisors (Steven Romick) | 3.5% | CNH, FBIN, CMCSA, BIO |
| Duquesne Family Office (Druckenmiller) | 2.9% | FLR, SNX, NUVB |
Read the 2026-Q2 quarterly report · 13F Filing Calendar
Frequently Asked Questions
What stocks does DME Capital Management (Greenlight, David Einhorn) hold as of Q3 2026?
DME Capital Management (Greenlight, David Einhorn) reported 45 positions worth $3.55B in its Q3 2026 13F filing. Largest positions: GRBK (17.6%), FLR (6.2%), CNR (5.5%), VGNT (4.1%) and BHF (4.0%).
What did DME Capital Management (Greenlight, David Einhorn) buy in Q3 2026?
New positions: CENX, SLG, ADIG, BIO and MGM (6 in all). Added to: VGNT, PCG, CMCSA, DCH and VTRS (10 in all).
What did DME Capital Management (Greenlight, David Einhorn) sell in Q3 2026?
Reduced: TEVA, ROIV, REZI, SNX and DHT (12 in all). Sold out entirely: PYPL, WBD, STUB, SPB and PSKY (7 in all).
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.